WRF Capital's book
21 companies · priced by our data| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| Xaira Therapeutics | Biotech | $3.5B | — | — | |
| Group14 Technologies | Other Materials | $3.3B | — | — | |
| Umoja Biopharma | — | $420.0M | — | — | |
| Tune Therapeutics | — | $340.0M | — | — | |
| Outpace Bio | Discovery Tools (Healthcare) | $220.0M | — | — | |
| Arzeda | — | $149.5M | — | — | |
| Vilya | — | $144.0M | — | — | |
| HyperSciences | — | $104.4M | — | — | |
| Cyrus Biotechnology | — | $45.5M | — | — | |
| AdaptX | — | $40.0M | — | — | |
| + 11 more companies · a free account shows the top 25 | |||||
Free account
See the whole book
- ·The book's top 25 — of 21 recorded positions
- ·Watchlist + alerts for WRF Capital's activity
Create free account
No card required